Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1997-05-05
2000-04-04
Jones, Dwayne C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514539, 514550, 514562, 564 80, 564 90, 564 92, 564 95, A01N 3712, A01N 3744, A61K 3124
Patent
active
060462361
ABSTRACT:
(1) Prostaglandin (PG) E.sub.2 antagonist or agonist containing carbocyclic sulfonamides represented by the compound of the formula (I): ##STR1## cyclodextrin clathrates thereof, non-toxic salts thereof as active ingredient,
(2) carbocyclic sulfonamides represented by the compound of the formula (II): ##STR2## cyclodextrin clathrates thereof, non-toxic salts thereof, (3) process for the preparation of the compound represented by the compound of the formula (II) described hereinbefore,
(4) PGE.sub.2 antagonist or agonist containing the compound represented by the compound of the formula (II) as active ingredient.
The compounds represented by the compounds of the formula (I) and (II) can be adapted to medicines which possess an inhibitory effect of uterine contraction, an analgetic action, an inhibitory effect of digestive peristalsis, a sleep-inducing effect as PGE.sub.2 antagonists, and an uterine contractile activity, a promoting effect of digestive peristalsis, a suppressive effect of gastric acid secretion, a hypotensive activity as PGE.sub.2 agonists, because they bind onto PGE.sub.2 receptor and have an activity of antagonist or agonist against the action thereof.
REFERENCES:
patent: 3644346 (1972-02-01), Cusic et al.
patent: 3773759 (1973-11-01), Cusic et al.
patent: 3978225 (1976-08-01), Bender et al.
patent: 4032656 (1977-06-01), Groves et al.
patent: 4132847 (1979-01-01), Kuhla et al.
patent: 4861913 (1989-08-01), Narisada et al.
patent: 5168101 (1992-12-01), Arai et al.
patent: 5180720 (1993-01-01), Husa et al.
patent: 5663417 (1997-09-01), Hamanaka et al.
Edward F. Smith, III, "Thromboxane A.sub.2 in Cardiovascular and Renal Disorders: Is There a Defined Role For Thromboxane Receptor Antogonists Or Thromboxane Synthase Inhibitors?", Eicosanoids (1989) 2: pp. 199-212.
Michael Theiry and Alex Yo Le Sian, "Reproductive Performance After Prostaglandin-Induced Labor," Prostaglandis, Apr. 1977, Volumn 13, No. 4, pp. 745-750.
Yetunde O. Taiwo and Jon D. Levine, "Effects of cyclooxygenase products of arachidonic acid metabolism on cutaneous nociecptive threshold in the rat," Brain Research, 537, (1990), pp. 372-374.
Toshiake Minami et al, "Blockade by ONO-NT-012, a unique prostanoid analogue, of prostaglandin E.sub.2 -induce allodynia in conscious mice," British Journal of Pharmacology, (1995), 115, pp. 73-76.
Hamanaka Nobuyuki
Miyamoto Tsumoru
Jones Dwayne C.
Ono Pharmaceutical Co. Ltd.
LandOfFree
Carbocyclic sulfonamides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carbocyclic sulfonamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbocyclic sulfonamides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-365810